The Plasmodium falciparum Rh5 invasion protein complex reveals an excess of rare variant mutations

Leonard Ndwiga1, Victor Osoti1, Kevin Omondi Ochwedo2

  • 1KEMRI-Wellcome Trust Research Programme, P.O. Box 230, Kilifi, 80108, Kenya.

Malaria Journal
|June 24, 2021
PubMed
Abstract

Insights

Genetic analysis of the Plasmodium falciparum Rh5 complex reveals low levels of genetic polymorphism in key merozoite invasion proteins, crucial for malaria vaccine development.

Area of Science:

  • Malariology
  • Genetics
  • Vaccine Development

Background:

  • The Plasmodium falciparum Rh5 complex (PfRh5-PfRipr-PfCyRPA-Pfp113) is essential for red blood cell invasion by merozoites.
  • These proteins are high-priority malaria vaccine candidates due to their conserved nature and ability to elicit neutralizing antibodies.

Purpose of the Study:

  • To investigate the genetic polymorphism within the Rh5 complex in Plasmodium falciparum isolates from Kilifi, Kenya.
  • To analyze the frequency and distribution of genetic variants in key invasion proteins.

Main Methods:

  • Genotyping of 162 samples using capillary sequencing (CS) and re-analysis of whole genome sequencing (WGS) data from 68 samples.
  • Examination of polymorphisms in PfRh5, PfRipr, PfCyRPA, and PfP113, including co-occurring variants.

Main Results:

  • A total of 70 variants were identified, with WGS identifying more SNPs than CS.
  • CS identified indels in the p113 gene not detected by WGS.
  • Twelve high-frequency SNPs (>5%) were found across Rh5, p113, and Ripr genes.

Conclusions:

  • The study identified a majority of rare variants, indicating a low overall level of genetic polymorphism in the Rh5 complex proteins.
  • This finding supports the potential of the Rh5 complex as a target for malaria vaccine development.